Adaptive Biotechnologies Corp (ADPT): Capital Expenditures
$2.96M
Year ended 2025-12-31
$3.02M
Trailing 12 months to 2026-06-30
-43.4%
3-year compound annual growth
-30.9%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.96M | -19.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $3.66M | -65.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $10.70M | -34.6% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $16.35M | -73.5% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $61.75M | +228.4% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $18.80M | +67.9% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $11.20M | +77.8% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $6.30M | +160.2% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $2.42M | n/a | 2020-02-26, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $2.96M | -19.2% |
| Vericel Corp (VCEL) | 2025-12-31 | $27.16M | -57.5% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $33.84M | +205.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $145.0K | -73.8% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $28.00M | +451.7% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $11.95M | +182.0% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $4.34M | -16.1% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $886.0K | -81.1% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $2.41M | -0.9% |
Compare ADPT, VCEL, IOVA, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗